RQ759883 Pharmaceuticals

The District of Columbia has issued a state and local contract opportunity identified as RQ759883 for Pharmaceuticals, with a solicitation posted on December 28, 2011, and a proposal submission deadline of January 2, 2012. While specific details about the procurement are limited in the provided information, the contract appears to be focused on pharmaceutical procurement for District government agencies. The procurement seeks vendors capable of supplying pharmaceutical products, though the exact scope, specific drug categories, or precise delivery requirements are not explicitly outlined in the available documentation. Given the short timeline between posting and submission dates, potential bidders would have been required to act quickly to prepare and submit their proposals. The contract opportunity suggests a focused, time-sensitive procurement process for pharmaceutical supplies, likely intended to meet the District's healthcare or institutional medication needs.

The contract opportunity does not provide explicit information about set-aside designations, disadvantaged enterprise requirements, or specific vendor restrictions. Without additional context, it is not possible to definitively state whether this procurement has preferences for local, small, minority-owned, or veteran-owned businesses. Similarly, no information is provided about incumbent vendors, existing contract infrastructure, or integration requirements. The potential award value, budget range, or estimated contract value is not specified in the available documentation. Interested vendors would have needed to carefully review the full solicitation documents to understand the complete requirements, evaluation criteria, and potential contract parameters. Prospective bidders would have been advised to closely examine the detailed request for qualifications and ensure compliance with all District of Columbia procurement guidelines and pharmaceutical supply regulations.